270 related articles for article (PubMed ID: 28086993)
1. Lack of partial renal response by 12 weeks after induction therapy predicts poor renal response and systemic damage accrual in lupus nephritis class III or IV.
Hanaoka H; Yamada H; Kiyokawa T; Iida H; Suzuki T; Yamasaki Y; Ooka S; Nagafuchi H; Okazaki T; Ichikawa D; Shirai S; Shibagaki Y; Koike J; Ozaki S
Arthritis Res Ther; 2017 Jan; 19(1):4. PubMed ID: 28086993
[TBL] [Abstract][Full Text] [Related]
2. Comparison of renal response to four different induction therapies in Japanese patients with lupus nephritis class III or IV: A single-centre retrospective study.
Hanaoka H; Kiyokawa T; Iida H; Ishimori K; Takakuwa Y; Okazaki T; Yamada H; Ichikawa D; Shirai S; Koike J; Ozaki S
PLoS One; 2017; 12(4):e0175152. PubMed ID: 28384208
[TBL] [Abstract][Full Text] [Related]
3. Early achievement of complete renal response predicts good long-term renal outcome and low systemic damage in newly diagnosed lupus nephritis class III or IV.
Hanaoka H; Kaneko Y; Kuwana M; Takeuchi T
Mod Rheumatol; 2015 Sep; 25(5):714-8. PubMed ID: 25563691
[TBL] [Abstract][Full Text] [Related]
4. Renal Remission Status and Longterm Renal Survival in Patients with Lupus Nephritis: A Retrospective Cohort Analysis.
Davidson JE; Fu Q; Ji B; Rao S; Roth D; Magder LS; Petri M
J Rheumatol; 2018 May; 45(5):671-677. PubMed ID: 29496892
[TBL] [Abstract][Full Text] [Related]
5. Treatment outcomes in refractory lupus nephritis: Data from an observational study.
Gururani S; Devarasetti PK; Uppin M; Rajasekhar L
Lupus; 2021 Oct; 30(11):1725-1731. PubMed ID: 34304627
[TBL] [Abstract][Full Text] [Related]
6. Glomerulomegaly in lupus nephritis: a prognostic marker for renal outcomes.
Hanaoka H; Kuwana M; Takeuchi T
Int J Rheum Dis; 2015 Sep; 18(7):768-75. PubMed ID: 26179413
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal patterns and predictors of response to standard-of-care therapy in lupus nephritis: data from the Accelerating Medicines Partnership Lupus Network.
Izmirly PM; Kim MY; Carlucci PM; Preisinger K; Cohen BZ; Deonaraine K; Zaminski D; Dall'Era M; Kalunian K; Fava A; Belmont HM; Wu M; Putterman C; Anolik J; Barnas JL; Diamond B; Davidson A; Wofsy D; Kamen D; James JA; Guthridge JM; Apruzzese W; Rao DA; Weisman MH; ; Petri M; Buyon J; Furie R
Arthritis Res Ther; 2024 Feb; 26(1):54. PubMed ID: 38378664
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological findings, treatment response and predictors of long-term outcome in a cohort of lupus nephritis patients managed according to the Euro-lupus regime: a retrospective analysis in Sri Lanka.
Herath N; Ratnatunga N; Weerakoon K; Wazil A; Nanayakkara N
BMC Res Notes; 2017 Feb; 10(1):80. PubMed ID: 28148285
[TBL] [Abstract][Full Text] [Related]
9. Outcome of lupus nephritis in childhood onset SLE in North and Central India: single-centre experience over 25 years.
Srivastava P; Abujam B; Misra R; Lawrence A; Agarwal V; Aggarwal A
Lupus; 2016 Apr; 25(5):547-57. PubMed ID: 26637291
[TBL] [Abstract][Full Text] [Related]
10. Effect of complete or partial proteinuria recovery on long-term outcomes of lupus nephritis.
Medina-Rosas J; Fung WA; Su J; Touma Z
Semin Arthritis Rheum; 2018 Feb; 47(4):557-564. PubMed ID: 28888363
[TBL] [Abstract][Full Text] [Related]
11. Induction therapy and outcome of proliferative lupus nephritis in the top end of Northern Australia - a single centre study retrospective study.
Xu C; Goh KL; Abeyaratne A; Priyadarshana K
BMC Nephrol; 2022 Jul; 23(1):235. PubMed ID: 35787253
[TBL] [Abstract][Full Text] [Related]
12. Rituximab in the treatment of resistant lupus nephritis: therapy failure in rapidly progressive crescentic lupus nephritis.
Davies RJ; Sangle SR; Jordan NP; Aslam L; Lewis MJ; Wedgwood R; D'Cruz DP
Lupus; 2013 May; 22(6):574-82. PubMed ID: 23632989
[TBL] [Abstract][Full Text] [Related]
13. Combination immunosuppressant therapy and lupus nephritis outcome: a hospital-based study.
Chen YM; Hung WT; Liao YW; Hsu CY; Hsieh TY; Chen HH; Hsieh CW; Lin CT; Lai KL; Tang KT; Tseng CW; Huang WN; Chen YH
Lupus; 2019 Apr; 28(5):658-666. PubMed ID: 30971165
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Lupus Nephritis Induction Treatments in a Hispanic Population: A Single-center Cohort Analysis.
Mejía-Vilet JM; Arreola-Guerra JM; Córdova-Sánchez BM; Morales-Buenrostro LE; Uribe-Uribe NO; Correa-Rotter R
J Rheumatol; 2015 Nov; 42(11):2082-91. PubMed ID: 26373566
[TBL] [Abstract][Full Text] [Related]
15. Comparing the efficacy of low-dose vs high-dose cyclophosphamide regimen as induction therapy in the treatment of proliferative lupus nephritis: a single center study.
Mehra S; Usdadiya JB; Jain VK; Misra DP; Negi VS
Rheumatol Int; 2018 Apr; 38(4):557-568. PubMed ID: 29450636
[TBL] [Abstract][Full Text] [Related]
16. Predictive factors for low rate of remission in a population of Colombian patients with severe proliferative lupus nephritis.
Pinto-Peñaranda LF; Duque-Caballero V; Márquez-Hernández JD; Muñoz-Grajales C; Velásquez-Franco CJ
Clin Rheumatol; 2015 May; 34(5):897-903. PubMed ID: 25592376
[TBL] [Abstract][Full Text] [Related]
17. Factors predictive of long-term mortality in lupus nephritis: a multicenter retrospective study of a Japanese cohort.
Ichinose K; Kitamura M; Sato S; Fujikawa K; Horai Y; Matsuoka N; Tsuboi M; Nonaka F; Shimizu T; Fukui S; Umeda M; Koga T; Kawashiri S; Iwamoto N; Tamai M; Nakamura H; Origuchi T; Nishino T; Kawakami A
Lupus; 2019 Mar; 28(3):295-303. PubMed ID: 30700214
[TBL] [Abstract][Full Text] [Related]
18. The prognosis of biopsy-proven lupus nephritis in chinese patients: long term follow-up of 86 cases.
Shen K; Yu Y; Tang Z; Liu Z; Li L
Chin Med J (Engl); 1997 Jul; 110(7):502-7. PubMed ID: 9594205
[TBL] [Abstract][Full Text] [Related]
19. Proteinuria selectivity index as a prognostic biomarker in lupus nephritis.
Hasegawa T; Suzuki K; Kaneko Y; Takeuchi T
Lupus; 2017 May; 26(6):656-660. PubMed ID: 27831538
[TBL] [Abstract][Full Text] [Related]
20. Tacrolimus versus mycophenolate mofetil for induction therapy of lupus nephritis: a randomised controlled trial and long-term follow-up.
Mok CC; Ying KY; Yim CW; Siu YP; Tong KH; To CH; Ng WL
Ann Rheum Dis; 2016 Jan; 75(1):30-6. PubMed ID: 25550339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
